Gilead Sciences funds community-based organizations to lead research improving health outcomes in HIV, oncology, and liver diseases through participatory, community-driven approaches.
Funder: Gilead Sciences
Due Dates (Anticipated): June 2026 (LOI) | September 2026 (Full application)
Funding Amounts: Award amounts and durations vary by project; typical CBPR grants cover direct and indirect costs for community-engaged research.
Summary: Supports community-based organizations to lead research that improves health outcomes in local populations, especially in HIV, oncology, and liver diseases.
Key Information: This is a projected/forecasted opportunity; timelines and details may shift—monitor the funder’s page for updates.
This program supports community-based participatory research (CBPR) projects led by organizations embedded in their local communities. Gilead Sciences aims to empower community-based organizations (CBOs) to define research priorities, design and implement studies, and evaluate solutions that address unmet health needs—particularly in therapeutic areas such as HIV, oncology, and liver diseases. The program values equitable partnerships, community engagement at all research stages, and projects that can demonstrate both immediate and sustainable impact on health outcomes.